QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.072
-- x --
-- x --
-- - --
$ 0.03 - $ 1.56
4,041
na
272,518
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 07-01-2025 03-31-2025 10-Q
3 04-14-2025 12-31-2024 10-K
4 01-17-2025 09-30-2024 10-Q
5 12-18-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-21-2023 09-30-2023 10-Q
9 08-21-2023 06-30-2023 10-Q
10 05-19-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 04-14-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-04-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-19-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-16-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 imac-hldgs-q1-eps-108-down-from-039-yoy-sales-1500k

IMAC Hldgs (OTC:BACK) reported quarterly losses of $(1.08) per share. This is a 176.92 percent decrease over losses of $(0.39) ...

Core News & Articles

RCL: 6% | Royal Caribbean shares are trading higher following a Q4 EPS beat despite missing on revenues. BACK: 160% | IMAC shar...

 us-stocks-futures-trade-higher-a-day-after-a-rout-in-nvidia-and-other-tech-stocks-investors-brace-for-fed-decision-big-tech-earnings

U.S. stock futures rebounded on Tuesday, recovering from significant technology sector losses as traders assess the viability o...

 imac-holdings-launches-ignite-proteomics-its-new-subsidiary-to-help-doctors-select-most-effective-cancer-treatments-based-on-protein-level-insights

This move addresses a growing need for better, faster ways to personalize therapy in breast cancer and beyond.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION